These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 8329141)

  • 21. Induction of apoptosis and cell cycle-specific change in expression of p53 in normal lymphocytes and MOLT-4 leukemic cells by nitrogen mustard.
    Bhatia U; Danishefsky K; Traganos F; Darzynkiewicz Z
    Clin Cancer Res; 1995 Aug; 1(8):873-80. PubMed ID: 9816057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [P53 mutations, asset or disadvantage for cancer chemotherapy].
    Jacquemin-Sablon A
    Bull Cancer; 1997 Jul; 84(7):741-6. PubMed ID: 9339201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The p53 gene and protein in 2005: new results, promising opportunities].
    Szoke D; Sipos F; Spisák S; Molnár B; Tulassay Z
    Orv Hetil; 2005 Jul; 146(30):1587-94. PubMed ID: 16136736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Function of the p53 gene: choice between life and death.
    Chumakov PM
    Biochemistry (Mosc); 2000 Jan; 65(1):28-40. PubMed ID: 10702638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Twenty years of p53 research: structural and functional aspects of the p53 protein.
    May P; May E
    Oncogene; 1999 Dec; 18(53):7621-36. PubMed ID: 10618702
    [No Abstract]   [Full Text] [Related]  

  • 26. Groups of p53 target genes involved in specific p53 downstream effects cluster into different classes of DNA binding sites.
    Qian H; Wang T; Naumovski L; Lopez CD; Brachmann RK
    Oncogene; 2002 Nov; 21(51):7901-11. PubMed ID: 12420228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Relevance of p53 protein and its mutations for novel strategies in cancer therapy].
    Müller P; Nenutil R; Vojtĕsek B
    Cas Lek Cesk; 2004; 143(5):313-7. PubMed ID: 15305766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53R2-dependent pathway for DNA synthesis in a p53-regulated cell cycle checkpoint.
    Yamaguchi T; Matsuda K; Sagiya Y; Iwadate M; Fujino MA; Nakamura Y; Arakawa H
    Cancer Res; 2001 Nov; 61(22):8256-62. PubMed ID: 11719458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
    Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM
    J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implication of p53 in base excision DNA repair: in vivo evidence.
    Seo YR; Fishel ML; Amundson S; Kelley MR; Smith ML
    Oncogene; 2002 Jan; 21(5):731-7. PubMed ID: 11850801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The p53 tumor suppressor gene.
    Levine AJ; Chang A; Dittmer D; Notterman DA; Silver A; Thorn K; Welsh D; Wu M
    J Lab Clin Med; 1994 Jun; 123(6):817-23. PubMed ID: 8201258
    [No Abstract]   [Full Text] [Related]  

  • 32. TP53 tumour suppressor gene: clues to molecular carcinogenesis and cancer therapy.
    Wang XW; Harris CC
    Cancer Surv; 1996; 28():169-96. PubMed ID: 8977035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antioncogene p53 and apoptosis response: new hypotheses on the molecular bases of tumor resistance to radiotherapy].
    Corvò R
    Radiol Med; 1996 Sep; 92(3):298-302. PubMed ID: 8975319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The significance of p53 mutations in human cancers.
    Pellegata NS; Ranzani GN
    Eur J Histochem; 1996; 40(4):273-82. PubMed ID: 9116334
    [No Abstract]   [Full Text] [Related]  

  • 35. Death squads enlisted by the tumour suppressor p53.
    Michalak E; Villunger A; Erlacher M; Strasser A
    Biochem Biophys Res Commun; 2005 Jun; 331(3):786-98. PubMed ID: 15865934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The genetics of the p53 pathway, apoptosis and cancer therapy.
    Vazquez A; Bond EE; Levine AJ; Bond GL
    Nat Rev Drug Discov; 2008 Dec; 7(12):979-87. PubMed ID: 19043449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controlling apoptosis: implications for carcinogenesis?
    Clarke AR
    Symp Soc Exp Biol; 2000; 52():265-75. PubMed ID: 12090014
    [No Abstract]   [Full Text] [Related]  

  • 38. [TP53 mutations and molecular epidemiology].
    Otsuka K; Ishioka C
    Gan To Kagaku Ryoho; 2007 May; 34(5):683-9. PubMed ID: 17496437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cell cycle regulation after exposure to ionizing radiation].
    Teyssier F; Bay JO; Dionet C; Verrelle P
    Bull Cancer; 1999 Apr; 86(4):345-57. PubMed ID: 10341340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [p53 as a molecular target for cancer therapy].
    Ishioka C; Osada M; Gamo M; Kanamaru R
    Gan To Kagaku Ryoho; 1997 Dec; 24(15):2207-12. PubMed ID: 9422063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.